Amy B P Ribet1, Pei Ying Ng1, Nathan J Pavlos1. 1. Bone Biology and Disease Laboratory, School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia.
Abstract
During bone resorption, the osteoclast must sustain an extraordinarily low pH environment, withstand immense ionic pressures, and coordinate nutrient and waste exchange across its membrane to sustain its unique structural and functional polarity. To achieve this, osteoclasts are equipped with an elaborate set of membrane transport proteins (pumps, transporters and channels) that serve as molecular 'gatekeepers' to regulate the bilateral exchange of ions, amino acids, metabolites and macromolecules across the ruffled border and basolateral domains. Whereas the importance of the vacuolar-ATPase proton pump and chloride voltage-gated channel 7 in osteoclasts has long been established, comparatively little is known about the contributions of other membrane transport proteins, including those categorized as secondary active transporters. In this Special Issue review, we provide a contemporary update on the 'ins and outs' of membrane transport proteins implicated in osteoclast differentiation, function and bone homeostasis and discuss their therapeutic potential for the treatment of metabolic bone diseases.
During bone resorption, the osten class="Gene">oclast must sustain an extraordinarily low pH environment, withstand immense ionic pressures, and coordinate nutrient and waste exchange across its membrane to sustain its unique structural and functional polarity. To achieve this, osteoclasts are equipped with an elaborate set of membrane transport proteins (pumps, transporters and channels) that serve as molecular 'gatekeepers' to regulate the bilateral exchange of ions, amino acids, metabolites and macromolecules across the ruffled border and basolateral domains. Whereas the importance of the vacuolar-ATPase proton pump and chloride voltage-gated channel 7 in osteoclasts has long been established, comparatively little is known about the contributions of other membrane transport proteins, including those categorized as secondary active transporters. In this Special Issue review, we provide a contemporary update on the 'ins and outs' of membrane transport proteins implicated in osteoclast differentiation, function and bone homeostasis and discuss their therapeutic potential for the treatment of metabolic bone diseases.
Authors: Niklas R Jørgensen; Lise B Husted; Kristen K Skarratt; Leanne Stokes; Charlotte L Tofteng; Torben Kvist; Jens-Erik B Jensen; Pia Eiken; Kim Brixen; Stephen Fuller; Rory Clifton-Bligh; Alison Gartland; Peter Schwarz; Bente L Langdahl; James S Wiley Journal: Eur J Hum Genet Date: 2012-01-25 Impact factor: 4.246
Authors: G Nadler; M Morvan; I Delimoge; P Belfiore; A Zocchetti; I James; D Zembryki; E Lee-Rycakzewski; C Parini; E Consolandi; S Gagliardi; C Farina Journal: Bioorg Med Chem Lett Date: 1998-12-15 Impact factor: 2.823
Authors: Gbolahan W Okunade; Marian L Miller; Gail J Pyne; Roy L Sutliff; Kyle T O'Connor; Jonathan C Neumann; Anastasia Andringa; Daniel A Miller; Vikram Prasad; Thomas Doetschman; Richard J Paul; Gary E Shull Journal: J Biol Chem Date: 2004-06-03 Impact factor: 5.157
Authors: Tina Schumann; Jörg König; Christine Henke; Diana M Willmes; Stefan R Bornstein; Jens Jordan; Martin F Fromm; Andreas L Birkenfeld Journal: Pharmacol Rev Date: 2020-01 Impact factor: 25.468
Authors: Bettina Groetsch; Elisabeth Schachtschabel; Philipp Tripal; Benjamin Schmid; Ana-Suncana Smith; Georg Schett; Aline Bozec Journal: Front Immunol Date: 2022-09-06 Impact factor: 8.786